Literature DB >> 3260133

Tumor infiltrating lymphocytes of spontaneous versus transplanted mouse mammary tumors.

W Z Wei1, G H Heppner.   

Abstract

Tumor infiltrating lymphocytes (TIL) were isolated by centrifugal elutriation from C4 mouse mammary tumors and characterized with regard to phenotype and natural killer (NK) activity. Tumors that had arisen spontaneously in preneoplastic hyperplastic alveolar nodules and tumors that had been passaged one to two times in either naive or presensitized mice were studied. Mice were sensitized by limited s.c. tumor growth and subsequent surgical removal of the tumor. The total numbers of T or B cells in the infiltrates were similar in spontaneous tumors and in passaged tumors from either naive or sensitized mice. The ratio of L3T4-positive to lyt-2-positive cells was reduced, however, from 1.10 +/- 0.2 in spontaneous tumors to 0.53 +/- 0.28 or 0.48 +/- 0.04 in passaged tumors from untreated or sensitized mice. The site of tumor implantation, whether intramammary fat pad or s.c., did not affect the profiles of the infiltrates. The TIL from both spontaneous and passaged tumors demonstrated enhanced NK activity relative to peripheral lymphoid cells. The TIL of passaged tumors sensitized mice, however, had lower NK activity than those from naive mice.

Entities:  

Mesh:

Year:  1988        PMID: 3260133     DOI: 10.1007/bf00199938

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  29 in total

1.  Clonal analysis of human tumor infiltrating lymphocytes reactive with autologous tumor cells: different target cell specificities of NK-like and cytotoxic T-cell clones.

Authors:  H Rabinowich; Z Steiner; A Klajman
Journal:  Cell Immunol       Date:  1987-02       Impact factor: 4.868

2.  Macrophage content of tumours in relation to metastatic spread and host immune reaction.

Authors:  S A Eccles; P Alexander
Journal:  Nature       Date:  1974-08-23       Impact factor: 49.962

3.  Macrophages in syngeneic animal tumours.

Authors:  R Evans
Journal:  Transplantation       Date:  1972-10       Impact factor: 4.939

4.  Effect of chemical carcinogen treatment on the immunogenicity of mouse mammary tumors arising from hyperplastic alveolar nodule outgrowth lines.

Authors:  B Ruppert; W Wei; D Medina; G H Heppner
Journal:  J Natl Cancer Inst       Date:  1978-10       Impact factor: 13.506

5.  In situ lymphoid cells of mouse mammary tumors. I. Development and evaluation of a method for the separation of lymphoid cells from mouse mammary tumors.

Authors:  B A Blazar; G H Heppner
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

6.  Depression of natural killer cytotoxic activity in lymphocytes infiltrating human pulmonary tumors.

Authors:  P M Moy; E C Holmes; S H Golub
Journal:  Cancer Res       Date:  1985-01       Impact factor: 12.701

7.  Concomitant tumor immunity in the mammary gland.

Authors:  F R Miller
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

8.  Monoclonal antibody to L3T4 blocks the function of T cells specific for class 2 major histocompatibility complex antigens.

Authors:  S L Swain; D P Dialynas; F W Fitch; M English
Journal:  J Immunol       Date:  1984-03       Impact factor: 5.422

9.  Possible host resistance in carcinoma of the breast: a histological study.

Authors:  I M Hamlin
Journal:  Br J Cancer       Date:  1968-09       Impact factor: 7.640

10.  Lymphocytes infiltrating human breast cancers lack K-cell activity and show low levels of NK-cell activity.

Authors:  O Eremin; R R Coombs; J Ashby
Journal:  Br J Cancer       Date:  1981-08       Impact factor: 7.640

View more
  3 in total

1.  Granulocyte-colony stimulating factor promotes invasion by human lung cancer cell lines in vitro.

Authors:  X H Pei; Y Nakanishi; K Takayama; J Yatsunami; F Bai; M Kawasaki; K Wakamatsu; N Tsuruta; K Mizuno; N Hara
Journal:  Clin Exp Metastasis       Date:  1996-09       Impact factor: 5.150

2.  Effect of indomethacin on tumor-infiltrating lymphocytes of a spontaneously developed murine mammary adenocarcinoma.

Authors:  T Y Chao; T M Chu
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

3.  Enhancement of tumorigenicity and invasion capacity of rat mammary adenocarcinoma cells by epidermal growth factor and transforming growth factor-beta.

Authors:  X Li; H Nagayasu; J Hamada; M Hosokawa; N Takeichi
Journal:  Jpn J Cancer Res       Date:  1993-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.